EUVIMEDEUVIMED entdecken
Crossref

Receipt of RhD‐positive whole blood for life‐threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti‐D

Molly R Sherwood iD, Skye Clayton iD, Christine M Leeper iD, Mark Yazer iD, Kenneth J Moise iD, Marion E Granger iD, Philip C Spinella iD

Transfusion · 2024

DOI: 10.1111/trf.17807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2024. Verfasst von Molly R Sherwood und 6 weiteren Autor:innen. Beteiligte Einrichtung: Allo Hope Foundation, Tuscaloosa, Alabama, USA. Hauptthemen laut MEDLINE: Rh-Hr Blood-Group System, Rh Isoimmunization. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Low‐titer group O whole blood (LTOWB) for treatment of hemorrhagic shock sometimes necessitates transfusion of RhD‐positive units due to short supply of RhD‐negative LTOWB. Practitioners must choose between using RhD‐positive LTOWB when RhD‐negative is unavailable against the risk to a female of childbearing potential of becoming RhD‐alloimmunized, risking hemolytic disease of the fetus and newborn (HDFN) in future children, or using component therapy with RhD‐negative red cells. This survey asked females with a history of red blood cell (RBC) alloimmunization about their risk tolerance of RhD alloimmunization compared to the potential for improved survival following transfusion of RhD‐positive blood for an injured RhD negative female child. Study Design and Methods A survey was administered to RBC alloimmunized mothers. Respondents were eligible if they were living in the United States with at least one red cell antibody known to cause HDFN and if they had at least one RBC alloimmunized pregnancy.

Results

Responses from 107 RBC alloimmmunized females were analyzed. There were 32/107 (30%) with a history of severe HDFN; 12/107 (11%) had a history of fetal or neonatal loss due to HDFN. The median (interquartile range) absolute improvement in survival at which the respondents would accept RhD‐positive transfusions for a female child was 4% (1%–14%). This was not different between females with and without a history of severe or fatal HDFN ( p = .08 and 0.38, respectively).

Conclusion

Alloimmunized mothers would accept the risk of D‐alloimmunization in a RhD‐negative female child for improved survival in cases of life‐threatening bleeding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rh-Hr Blood-Group SystemRh IsoimmunizationHumansFemalePregnancyAdultRho(D) Immune GlobulinInfant, NewbornIsoantibodiesErythroblastosis, FetalBlood Transfusion

Stichwörter der Autor:innen

HDFNLTOWBRh diseaseRh‐positive bloodalloimmunizationanti‐Dhemolytic disease of the fetus and newbornhemorrhagelow titer group O whole bloodtransfusionwhole blood

Substanzen

Rh-Hr Blood-Group SystemRho(D) Immune GlobulinIsoantibodiesRHO(D) antibodyRho(D) antigen

Autor:innen und Institutionen

  • Allo Hope Foundation, Tuscaloosa, Alabama, USA.
  • Trauma and Transfusion Medicine Research Center, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Women's Health, Dell Medical School-UT Health, Austin, Texas, USA.
  • Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, South Carolina, USA.

ORCID-Profile: Molly R Sherwood, Skye Clayton, Christine M Leeper, Mark Yazer, Kenneth J Moise, Marion E Granger, Philip C Spinella

Zitieren

APA

Sherwood, M. R., Clayton, S., Leeper, C. M., Yazer, M., Moise, K. J., Granger, M. E., & Spinella, P. C. (2024). Receipt of RhD‐positive whole blood for life‐threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti‐D. Transfusion. https://doi.org/10.1111/trf.17807

Vancouver

Sherwood MR, Clayton S, Leeper CM, Yazer M, Moise KJ, Granger ME, et al. Receipt of RhD‐positive whole blood for life‐threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti‐D. Transfusion. 2024. doi:10.1111/trf.17807

BibTeX
@article{Sherwood2024,
  author = {Sherwood, Molly R and Clayton, Skye and Leeper, Christine M and Yazer, Mark and Moise, Kenneth J and Granger, Marion E and Spinella, Philip C},
  title = {Receipt of RhD‐positive whole blood for life‐threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti‐D},
  journal = {Transfusion},
  year = {2024},
  doi = {10.1111/trf.17807}
}
Kostenlos starten →